spacer
home > ebr > spring 2007 > cells, gels and alginates
PUBLICATIONS
European Biopharmaceutical Review

Cells, Gels and Alginates

As alginate-based products become increasingly accepted, Are Kristiansen, Therese Andersen and Jan Egil Melvik at NovaMatrix speculate upon the likelihood that more and more will find their way onto the market

Alginates were first described by British chemist Stanford in 1881 (1), and are the most abundant polysaccharide in cell walls and intercellular space of brown algae (seaweed and kelp). Alginates are also produced by bacteria such as Azotobacter vinelandii and some Psedumonas species. They are a family of linear molecules composed of (1,4)-linked β-D-mannuronate (M) and α-L-guluronate (G), where the relative content of M and G is source-dependent. Alginates have been used for several decades in the food and pharmaceutical industries as emulsifying, thickening, film-forming and gelling agents, and they are also well-known in the biomedical and biotechnology arena. This article gives a brief review of the technology of cell immobilisation in alginates, and identifies and discusses new strategies and developments in the field. Furthermore, the aspects of standardisation and regulatory acceptance of alginates are discussed.

BASIC ALGINATE CHEMISTRY

The relative amount of M and G and their sequential arrangement along the polymer chain varies widely depending on the source. The monomer residues are distributed along the polymer chain in a block pattern, where homopolymeric blocks of G-residues, homopolymeric blocks of M-residues, and alternating sequences of M and G-units (MG-blocks) co-exist (see Figure 1). The content and distribution of the two monomers largely determines the physicochemical properties of alginates. Commercial alginates derived from seaweed and kelp typically have G-contents in the range of 30-70 per cent, and number-average Gblock lengths (excluding single Gs), NG>1 of 4-20. The latter parameter largely determines the ability of alginates to form strong gels through interaction with multivalent cations. pKa-values of M- and G-units are 3.38 and 3.65 respectively, therefore, alginates are polyanions at physiological conditions. The polymer chain length of commercially available alginates is in the range of 30-500kDa. The molecular weight strongly affects the viscosity of a solution containing alginate.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer

Are Kristiansen holds a PhD in Biopolymer Chemistry and is R&D Manager at NovaMatrix with a background and long experience in the fields of biopolymer chemistry and technology. He has previously held various positions in the company in R&D, process development, and commercial development.

Therese Andersen holds a MSc in Biopolymer Chemistry. She is an R&D Scientist at NovaMatrix and is a strong contributor and inventor in the development of new biostructures and biopolymer technologies.

Jan Egil Melvik holds a PhD in Biophysics and is Senior Scientist at NovaMatrix, with much experience of biopolymer technologies, including development of new biostructures and cell immobilisation technologies. He has been a key driver in the development and innovation of alginates.

spacer
Are Kristiansen
spacer
spacer
spacer
Therese Andersen
spacer
spacer
spacer
Jan Egil Melvik
spacer
spacer
Print this page
Send to a friend
Privacy statement

Industry Events

First-in-Human Workshop

7-8 May 2012, Berlin, Germany


More info >>

 
News and Press Releases

Norwich Expands Capabilities for Phase I-III Clinical Trials

Norwich Clinical Services (NCS), a global provider of clinical research services for the pharmaceutical and biotech industries, today announced a significant expansion to its clinical research capabilities in order to meet growing market demand. Primary to the expansion, NCS unveiled a new clinical facility with capabilities to conduct all aspects of Phase I – III clinical trials including pharmacokinetics in healthy volunteers, bio-availability and bio-equivalence studies, drug metabolism studies, dose proportionality studies and multiple dose studies.
More info >>

 

 

Buy Atrovent Online no prescription Buy Symbicort Online no prescription Buy Flovent Online no prescription Buy Flonase Online no prescription Buy Rhinocort Online no prescription Buy Allegra Online no prescription Buy Advair Online no prescription Buy Combivent Online no prescription Buy Astelin Online no prescription Buy Spiriva Online no prescription Buy Ventolin Online no prescription
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement
.